Evaluation of paediatric patients with protein losing enteropathy a single centre experience

N Urganci1, S G Gulec2, D Kalyoncu2

  • 1Department of Paediatric Gastroenterology, Sisli Etfal Training and Research Hospital, Istanbul, Turkey.

Insights

Protein losing enteropathy (PLE) in children can stem from various causes like celiac disease or infections. Prompt diagnosis and targeted treatment are key for managing this condition effectively.

Area of Science:

  • Pediatric Gastroenterology
  • Internal Medicine

Background:

  • Protein losing enteropathy (PLE) is a complex condition characterized by excessive protein loss into the gastrointestinal tract.
  • Understanding the diverse etiologies and clinical presentations of PLE in pediatric populations is crucial for effective management.

Purpose of the Study:

  • To evaluate pediatric patients diagnosed with protein losing enteropathy (PLE).
  • To analyze the etiologies, diagnostic approaches, laboratory findings, treatment strategies, and long-term outcomes of pediatric PLE cases.

Main Methods:

  • Retrospective evaluation of fourteen pediatric patients diagnosed with PLE.
  • Assessment of underlying causes, diagnostic methods employed, laboratory results, treatment regimens, and patient prognoses.

Main Results:

  • Identified etiologies included celiac disease (4 cases), intestinal lymphangiectasia (3 cases), giardia infection (3 cases), H pylori infection (1 case), and cytomegalovirus (CMV) infection (3 cases).
  • Histopathological findings varied, with total villous atrophy, lymphatic dilatation, and nodular appearance noted in duodenal biopsies.
  • Most cases achieved remission with treatment targeting the underlying cause; CMV infections were managed with supportive care, avoiding ganciclovir.

Conclusions:

  • Protein losing enteropathy (PLE) should be considered in well-appearing children presenting with edema, even in the absence of proteinuria.
  • Timely diagnosis and appropriate treatment of the underlying condition are essential for favorable outcomes in pediatric PLE.
Abstract

Related Concept Videos

Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
4.5K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
679
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
409
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
1.2K